International
Pharmatech, Inc. has developed strategic collaborations with sites in Hong Kong and Eastern Europe. Through these relationships, we can significantly increase the number of potential study subjects, especially in smaller indications or non-standard-of-care treatment options in the US. Sponsors can select to work with these sites directly, or have Pharmatech, Inc. manage the international component of your studies.
PHARMATECH ONCOLOGY ANNOUNCES BEING ON-TARGET FOR SETTING A RECORD GROWTH YEAR FOR 2012
11/5/2012
PHARMATECH ONCOLOGY ANNOUNCES PROGRESSION TOWARDS COMMERCIALIZING ITS DOCUMENT MANAGEMENT SYSTEM
10/22/2012
PHARMATECH ONCOLOGY ANNOUNCES WENDY GARZA AS NEW CONTROLLER
8/25/2012
8/13/2012
Pharmatech Oncology Announces Collaboration with PCM Trials for In-Home Study Visits
5/3/2012
